Article Information
History
- December 21, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Louise A Organ, PhD1,
- Anne-Marie R Duggan, MSc2,
- Eunice Oballa, MSc2,
- Sarah C Taggart, MSci2,
- Juliet K Simpson, PhD2,
- Arthur R Kang’ombe, MSc2,
- Rebecca Braybrooke, RGN1,
- Philip L Molyneaux, MD, PhD3,4,
- Diana J Leeming, PhD5,
- Morten A Karsdal, PhD5,
- Carmel B Nanthakumar, PhD2,
- William A Fahy, MD2,
- Richard P Marshall, MD, PhD2,
- R Gisli Jenkins, MD, PhD1 and
- Toby M Maher, MD, PhD3,4
- 1University of Nottingham, Division of Respiratory Medicine, Nottingham, UK.
- 2Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK.
- 3NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK.
- 4Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK.
- 5Nordic Bioscience A/S, Biomarkers and Research, Herlev Hovedgade 205207, DK-2730, Herlev, Denmark.
- Address for correspondence
: Toby M Maher, Fibrosis Research Group, Inflammation, Repair & Development Section, NHLI, Sir Alexander Fleming Building, Imperial College, London, SW7 2AZ. E-mail: t.maher{at}imperial.ac.uk Tel: +44 207 351 8018 Fax: +44 207 351 8951 Or R Gisli Jenkins, Respiratory Research Unit, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, E-mail gisli.jenkins{at}nottingham.ac.uk Tel: +44 115 823 1711 Fax +44 115 823 1946